University of Mississippi

eGrove
Honors Theses

Honors College (Sally McDonnell Barksdale
Honors College)

Spring 5-7-2022

Population Aging and Healthcare Costs in China and Japan
Sean Brown

Follow this and additional works at: https://egrove.olemiss.edu/hon_thesis
Part of the Asian Studies Commons, Demography, Population, and Ecology Commons, and the Health
Economics Commons

Recommended Citation
Brown, Sean, "Population Aging and Healthcare Costs in China and Japan" (2022). Honors Theses. 2466.
https://egrove.olemiss.edu/hon_thesis/2466

This Undergraduate Thesis is brought to you for free and open access by the Honors College (Sally McDonnell
Barksdale Honors College) at eGrove. It has been accepted for inclusion in Honors Theses by an authorized
administrator of eGrove. For more information, please contact egrove@olemiss.edu.

POPULATION AGING AND HEALTHCARE COSTS IN CHINA AND JAPAN

© 2021
By Sean H. Brown

A thesis presented in partial fulfillment of the requirements for completion
Of the Bachelor of Arts degree in International Studies
Croft Institute for International Studies
Sally McDonnell Barksdale Honors College
The University of Mississippi

University, Mississippi November 2021

Approved:
_________________________________
Advisor: Dr. Gang Guo
_________________________________
Reader: Dr. Vanessa Parks
_________________________________
Reader: Dr. Oliver Dinius

Abstract
This study focuses on the natural demographic phenomenon known as population aging and its
intersection with healthcare expenditures. Healthcare spending can be a major burden on a
country’s economy, so it is important to accurately assess the connection between these two
factors. Population aging occurs when countries reach a point in their demographic transitions
characterized by declining total fertility rates and high life expectancy. This natural but
undesirable position has implications for virtually all aspects of society, and all countries are
trending towards aging. This study examines the cases of China and Japan in an effort to assess
the validity of the wider, global observation of the relationship between population aging and
healthcare expenditures. Cross-sectional and time series quantitative analyses reveal a
statistically significant, non-spurious correlation between the two variables with a high degree of
magnitude. This study discusses the implications of those findings within the broader context of
population aging as a global issue.
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Chapter 1: Introduction
This study focuses on the natural demographic phenomenon known as population aging.
Population aging occurs when countries reach a point in their demographic transitions
characterized by declining total fertility rates (TFR) and high life expectancy. The former stems
from a combination of widespread contraceptive use, lifestyle choices influenced by economic
prosperity, and more opportunities for women in the workforce, among others, which often
means the delaying of childbearing until later in life and having fewer children total, while the
latter results from advancements in medical technology and an economic transition away from
manual labor jobs that are more dangerous than those found in the primarily service-based
economies of the Global North (the term Global North refers to the world’s most developed and
affluent countries) [Roser 2013].
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Historically, only nations of the Global North have encountered this problem, with Japan
being one of the most extreme examples of population aging in the world (Arai et al. 2015).
Japan has a median age of 48.4 years old, meaning half of the country’s entire population is that
age or older, and 27.6 percent of the population is age 65 or above (United Nations 2019). To put
this into perspective, the United States (a developed country that has been able to somewhat
stave off population aging through immigration) has a median age of 38.3 years old and 15.8
percent of its total population at or above the age of 65, while on the other end of the spectrum
the rapidly growing country of Niger sits at a median age of just 15.2 years old and only 2.6
percent of its population at age 65 or above (United Nations 2019). Even when compared with its
fellow OECD member countries, Japan still ranks as the most aged among them.
As it stands, Japan is the second oldest population in the world as measured by both
median age and percent of population age 65 and above, trailing only the tiny principality of
Monaco, which has a median age of 55.4 years old and a population with 35.15 percent of people
at age 65 or above (United Nations 2019). For reference, Italy comes in at number 5, France at
44, the United States at 62, China at 63, Brazil at 102, and Niger at 230, with the averages of all
countries being 30.6 years old for median age and 8.75 percent for population age 65 and above
(United Nations 2019). For developed nations, these are 42 years old for median age and 15
percent for population age 65 and above, and for East Asia and the Pacific the averages are 32
years old for median age and 11.6 for percent of population age 65 and above (United Nations
2019). This makes Japan’s median age of 48.4 years old and the percentage of its population age
65 and above of 27.6 percent all the more striking.
The natural but undesirable position of having an aging society has implications for
virtually all aspects of society, including those both economic and cultural (Roser 2013). These
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include but are certainly not limited to the following: stunted economic growth or even decline,
unhealthy fluctuations in inflation rates, a straining of the government’s ability to provide
adequate social and medical resources for elderly people, changes in the responsibilities and
functioning of the family (often manifesting in the form of increased stress placed on younger
members to care for elder members, as the latter grow in number while the former decline), and
shifting practices of work and retirement [Vlandas 2018]. For example, because they are almost
all retired, elderly people do not contribute nearly as much to a country’s economy as do its
working-age citizens. Thus, one of the main negative consequences of population aging is that a
dwindling number of working-age people must prop up the economy of a society increasingly
comprised of the elderly, which includes all of the healthcare provided for them. This creates a
situation in which population sizes and economies shrink in tandem (Vlandas 2018). For
example, Japan’s current population of approximately 126 million people is expected to decrease
to around or below 100 million by 2050 (Statistical 2017). Its economic output (as measured by
GDP per capita) is also projected to see negative growth rates beginning in 2030 [Yasutake
2012].
However, it is important to note that while Europe and parts of Asia may have reached
this point first, all countries are trending towards population aging as a natural byproduct of
social and economic development (Roser 2013). Every society on Earth is in some stage of
demographic transition that closely resembles past stages of the world’s most aged populations,
and while individual cases of course differ in their details, there have never been any exceptions
to this rule (Vlandas 2018). As a result, as the world’s population continues to get older, it is
imperative to understand the far reaching impacts of the population aging phenomenon.
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Arguably the most discussed aspect of population aging is the nature of its relationship
with healthcare expenditures. Healthcare spending can be a major burden on a country’s
economy, so it is important to accurately assess the connection between these two factors. While
much of the extant literature points to a causal relationship, many scholars are still debating
exactly what those causes are, how that connection manifests, the strength of said connection,
and what overall effect it has on a given nation’s healthcare expenditures, particularly when
factoring in that nation’s unique economic, social, and cultural attributes.
To that end, this study will examine the situations of China and Japan in an effort to
assess the validity of the wider, global observation of the relationship between population aging
and healthcare expenditures. These two Northeast Asian neighbors are worthwhile case studies
for the broader issue of population aging because while they have commonalities, their
differences are much more pronounced, and they represent two contrasting aging situations.
Culturally, both countries have long held a respect for the elderly, emphasizing the value and
wisdom that comes with age (Hinton 2016). The concept of filial piety, or demonstrating respect
for and deference to one’s elders, in China is but one example (Chen 2010; Jiang 2011). China
and Japan also share a similar importance placed on the nuclear family, meaning smaller familial
units are prioritized over the extended family (Hinton 2016; LaFave 2017). Overall, aging
occupies a similar cultural space in these neighboring East Asian nations. Furthermore, both are
large, populous countries with two of the most influential economies in the world.
However, there exist important differences that make them useful as a critical test for the
larger theory on the relationship between aging and healthcare spending. Generally, though both
countries are considered populous nations, they still vary substantially in actual population size.
Japan’s current population of 126 million is only a fraction of China’s enormous 1.4 billion
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(United Nations 2019). They also contrast geographically, with China being much larger and
diverse compared to the mountainous island nation of Japan, which is another factor that has
influenced both nations’ social and economic development throughout history.
The countries vary in terms of their governance as well. While they both have been under
the control of a single dominant political party for much of their recent histories, those being the
Liberal Democratic Party for Japan and the Communist Party for China, the superficial
similarities end there. Japan is a liberal democracy with constitutionally protected freedoms of
speech and the right to vote, whereas China is an authoritarian state that does not grant voting
freedoms at the national level. When a free population like Japan ages, older cohorts naturally
gain political power because members of older cohorts outnumber those of younger cohorts and
thus are more likely to be elected. In contrast, a place like China, with only one political party,
does not change power based on population age as much because political power is so
centralized. This could affect how the popular pressure to increase healthcare spending plays out
over time, and this difference makes the two nations even more useful for comparison.
Japan and China have also had different histories regarding economic growth and volatile
political periods. In terms of the former, following World War II Japan experienced an economic
boom up until the 1990s when that growth began to stagnate. That period is now referred to as
the country’s “lost decade”, the ramifications of which have continued to plague the Japanese
economy (信夫 2010). However, the country was at least in a much more stable position
politically when compared to China during the same time period. In contrast, following China’s
“opening up” to the rest of the world in 1978, the reforms associated with which spurred the
country’s rapid economic growth that has, despite a significant but temporary lull during the
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political unrest brought about by the 1989 Tiananmen Square protests, steadily continued to the
present, only in recent years having begun to somewhat slow down (Jiang 2016; Shi 2018).
Moreover, since Japan has one of the oldest populations in the world, it is in many ways a
glimpse into the near future for many countries just beginning to grapple with population aging
(Arai et al. 2015). China is one of those countries, but it is facing a looming aging crisis wholly
unique to its own circumstances. Specifically, China has not reached the same levels of aging as
Japan or some other greying nations, but it is a special case, as its population aging is occurring
prematurely (Kong 2019). China is not yet considered a developed nation, sitting somewhere in
stage 3 of the demographic transition model, while developed countries are classified as stage 4
and 5. Figure 1 below shows in detail the population characteristics of each stage of the
demographic transition model, with a focus on the movements of birth rates and death rates and
how that impacts total population growth.

Figure 1: Demographic Transition Model.
Source: Roser, Max, Hannah Ritchie, and Esteban Ortiz-Ospina. “World Population Growth.” Our World in Data,
May 9, 2013. https://ourworldindata.org/world-population-growth.
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Using China as an example to put the above chart in economic terms, China is currently
ranked 79th in the world with a GDP per capita of $10,500, which is far behind a nation like
Japan, which is ranked 28th and, even with a recent decline, still has a GDP per capita four times
that of China at $40,113 (United Nations 2019). However, just like Japan, China is already
grappling with the effects of population aging (Cheng 2019; Jiang 2011; Kong 2019). Recent
literature suggests that the country’s former One Child Policy, in effect from 1980 to 2015 and
originally intended to slow China’s then explosive population growth, actually functioned as an
overcorrection (Feng et al. 2014). These analyses support the theory that by the time the policy
was implemented, China had in fact already completed the bulk of its demographic transition and
was going to see declining fertility rates anyway. This resulted in the artificial acceleration of the
nation’s aging as birth rates plummeted while the country continued to modernize, improving life
expectancy but forcing upon the still developing nation a societal issue previously exclusive to
already developed countries on a scale never before seen. Scholars question to what extent
China’s current healthcare infrastructure will be able to support a growing number of elderly
people, especially in regards to long term care and elder care (Chen 2010; Cheng 2019; Nie
2016).
In many respects China and Japan are vastly different countries, varying greatly in
population size, population distribution, geography, level of development, stage of demographic
transition, and type of governance, among others, all of which have had an impact on each
nation’s social and economic development throughout history. However, despite all of their
differences, they are both facing the same major societal problem. As such, it will prove
worthwhile to examine to what extent the relationship between aging and healthcare spending
manifests in these two otherwise contrasting nations. If, despite all their differences, the
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relationship between said variables can still be seen in both countries, then it will allow for a
higher degree of confidence in this study’s findings. This makes China and Japan especially
worthwhile as a least similar pair for comparison and analysis. The results of which could
illuminate common trends across the two nations as well as effects unique to each. This would
not only prove helpful in explaining China and Japan’s respective situations, but it would also be
generalizable to other countries, both those who have not yet encountered the aging population
phenomenon and those who are already dealing with it.
The following research paper utilizes a quantitative analysis approach consisting of
primary data analysis of data gathered from various governmental and non-governmental sources
to examine the effects of population aging on healthcare expenditures in China and Japan. The
primary data analysis consists of two main subsections - a cross-sectional portion and a
time-series portion. The main methods used in each are linear regressions and correlations. This
is done in order to answer the study’s chief research question, which investigates the impact of
increasing population aging on total annual healthcare expenditures both across the world and in
China and Japan specifically, with the prediction being that a statistically significant relationship
will be found that shows healthcare spending increases with an increasing severity of population
aging. Indeed, the findings reveal a tight relationship between the two main variables, as well as
a strong degree of magnitude, that together show definitively that population aging is a
substantial driver of healthcare spending across all countries, including China and Japan, even
when controlling for gross domestic product per capita.
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Chapter 2: Literature Review
For the issue of population aging in general, there exists an ongoing debate over how
healthcare expenditures will increase in the near future and how population aging will contribute
to that trend. While there is little disagreement regarding the fact that healthcare expenditures
and population aging are causally linked, much of the extant literature is divided over to what
extent that causal relationship exists and in what ways it manifests. As population aging is not a
phenomenon unique to China and Japan, it is beneficial to first examine how the topic is treated
in the literature regarding other aging nations.
For example, de Meijer et al. look at population aging and healthcare expenditures in
Western nations overall. While looking at these two variables, the authors do frame their
relationship as being causal in nature, but they suggest it manifests indirectly rather than directly.
In writing that “Population aging moderately increases expenditures on acute care and strongly
increases expenditures on long-term care,” the authors are noting that the effects of aging on
different subtypes of healthcare spending vary (de Meijer et al. 2013). They theorize that
population aging first impacts the main societal factors responsible for changes in healthcare
expenditures, such as advancements in medical technology (de Meijer et al. 2013).
Similarly, Milena et al. use a quantitative analysis model to evaluate the relationship
between healthcare expenditures and population aging in Italy. Their results show that Italy’s
healthcare expenditures are more closely correlated with population aging itself, rather than other
similar metrics such as life expectancy or GDP per capita (Milena 2017).
In their study examining elder care spending in China, Jiang et al. also found that
“Health-related bills are the major driver pushing up the elderly’s consumption,” which is “due
to the changing population age structure” (Jiang et al. 2016). The study frames China’s rising
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healthcare costs as a direct consequence of population aging, and they use health statistics to
draw a causal link between health expenditures and demographic changes, stating that medical
bills are primarily responsible.

Multimorbidity and Chronic Illness
A major trend seen in the literature is the association of multimorbidity (the condition of
having more than one disease or illness) and chronic illness in the elderly with increased
healthcare costs and usage. As Europe was the first continent to experience widespread
population aging, much of the literature on said topic is based in the situations of European
nations, especially those in western Europe.
For example, one study looked at the direct effects of multimorbidity, which is naturally
more prominent in the elderly, on healthcare costs in Germany (Marengoni et al. 2011).
Compiling a multimorbidity index and making use of multivariate linear regression models, the
authors analyzed the impact of elderly multimorbidity on direct healthcare costs and health
service and resource utilization. Their results found the following breakdown of individual
patient costs among their cross sectional sample of persons age 72 and older: “25% of mean
annual costs were due to inpatient care, 20% to outpatient physician services, 20% to
pharmaceuticals, 12% to assisted living and transportation, 8% to healthcare products and
dentures, 7% to rehabilitation services, 5% to outpatient nonphysician providers, and 3% to
spending from compulsory long-term care insurance” (Nagl et al. 2012). They conclude that
multimorbidity leads to increased personal healthcare costs as well as health service
consumption, meaning that the elderly population are driving up healthcare costs and resource
usage through the need for simultaneous care for multiple conditions (Nagl et al. 2012).
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The topics of multimorbidity and chronic illness are closely intertwined, as people
become more susceptible to both as they age. Graves and Zheng see similar findings in their
assessment of chronic wounds and direct healthcare costs in Australia. They note that healthcare
costs associated with chronic afflictions are substantial, stating that “As the elderly population
grows, costs are likely to rise unless cost-effective intervention strategies are implemented as a
matter of routine” (Graves 2014). Here the authors suggest that these chronic wounds and
illnesses will become more commonplace, indicating a need for structural reform in healthcare
provision as population aging continues.
A literature review of 35 studies on chronic illnesses and multimorbidity lends credence
to the findings of the Nagl et al. and Graves studies. In looking at the relationship between
elderly with multiple chronic conditions (MCCs) and healthcare cost and utilization, the review
found that “almost all studies observed a positive association of MCCs and use/costs, many of
which found that use/costs significantly increased with each additional condition. Several studies
indicate a curvilinear, near exponential relationship between MCCs and costs” (Lehnert et al.
2011). This is further evidence that people with for the most part inherently elderly health
complications are contributing to a noticeable increase in healthcare service and resource use
costs that is not seen in any other age demographic.

The “Red Herring” Effect
I also came across papers discussing what is known as the “red-herring” effect, which is
used by some social scientists to describe a perceived overstated emphasis on population aging
as a driver for increased healthcare costs. However, this is a contested issue, as the literature on
this specific topic is divided into camps that either accept or reject the red-herring theory.
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For example, one study employed a multi-stage data modeling process to examine
healthcare expenditures and population aging in South Korea. They found little evidence to
support the claim that aging has a significant impact on healthcare expenditures (Hyun et al.
2016). Conversely, Aaron acknowledges the common argument among red herring proponents
that healthcare expenditures are more closely tied to individual proximity to death rather than
age, but he expresses uncertainty by stating, “available data provide no basis for assuming that
the curve relating average health care spending to age will, or will not, flatten with increases in
longevity,” which points to a general lack of agreement among scholars on the topic as a whole
(Aaron 2009).
Studies that do find a positive relationship between the two variables often mention the
limitations of this correlation. A report from the World Health Organization that looked at
longitudinal health expenditure data for the European Union and Japan found that while
population aging does appear to increase healthcare spending, it does so to a lesser extent than
initially expected. Instead, the authors attribute the bulk of growth in spending to price changes
and technological advancement, especially in the case of Japan, which is a conclusion also found
in the de Meijer article (Williams et al. 2019). On the other hand, Breyer examines the body of
literature on the red herring hypothesis itself and argues that it obscures the need for meaningful
policy change to combat the intertwined and very real threats of population aging and rising
healthcare costs, claiming that the bulk of studies on the red herring effect are inconclusive at
best (Breyer 2020).
Japan and China’s cases are already interesting separately, so reexamining the issue of
population aging through both of their situations together is illuminating, especially when there
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is considerable debate among experts on the strength of the effect of population aging on
healthcare expenditures as a broader issue facing nations.

Chapter 3: Theoretical Framework
The theoretical framework provides a more qualitative, descriptive analysis of the extant
literature, with the primary function being to supplement the findings from the quantitative
portion of this project through the identification of prevailing trends that, when put together, help
paint a more complete picture of the impact of population aging on healthcare expenditures.
Specifically, this section expounds upon the main theoretical trends within the relevant body of
literature, which are as follows: old-age insurance and old-age healthcare systems across China
and Japan, multimorbidity and chronic illness, and long-term care. The goal in doing so is to
provide a theoretical framework to act as a foundation for my findings, against which the
quantitative findings of the main analysis will be compared.
First, it is important to clarify what types of healthcare systems each country has and
what reforms led to their current states. Starting with Japan, Western medicine found its way to
the country following the Meiji Restoration of 1868, and employee health insurance was
instituted in 1927. In 1961 the country’s government established a modern and more or less
equitably distributed universal health insurance system consisting of two main types of coverage:
national and employer-based (Arai et al. 2015). Just as they sound, employer-based is provided
through a person’s workplace, while national health insurance is provided directly through the
Japanese government. Private insurance does exist, but all citizens must enroll in either national
or employee regardless (Arai et al. 2015). Furthermore, a person who has recently lost their job
will have their insurance policy automatically switched over from that of their former employer
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to that of the national health insurance provider, as they are no longer eligible for
company-provided insurance (Arai et al. 2015). This system covers over 90% of Japanese
citizens, who on average pay around ten percent to no more than a third of the total cost of any
medical procedure or doctor’s visit, the prices of which are set every one to two years by a
government committee with the aim of maintaining affordability (厚生労働省 2014). Just as
with company-provided insurance, Japan has a compulsory public long-term care insurance
system established for retirees (Inoue 2013). Also, healthcare quality generally matches or
exceeds that of the United States in most metrics (Shimizutani 2014; Steslicke 1984). Lastly of
note is that under Japanese law, hospitals are not allowed to make a profit (Inoue 2013). This is
to say that though not without its problems, the Japanese government has continued to refine its
healthcare system into one of the best in the world today (Shimizutani 2014).
In China however, traditional Chinese medicinal practices did not give way to modern
medicine until the 1950s after the Communist Party took control of the country. Then the state
nationalized healthcare and sponsored programs aimed at improving the basic health and hygiene
of Chinese citizens, but the nation’s healthcare system was still very much in its infancy (Cheng
2019). The quality, affordability, and accessibility of urban and rural health coverage began to
diverge significantly following the country’s opening up, and these discrepancies went mostly
unaddressed until 2006 when the Chinese government embarked on its ongoing mission to
overhaul and modernize its healthcare system (Jiang 2016). Progress has been made, notably the
granting of basic but affordable medical care to hundreds of millions of citizens under the New
Rural Cooperative Medical Care System (国家卫生健康委 2021).
Currently in China, there exist both public and private healthcare and insurance
institutions that together provide coverage to nearly all (97%) Chinese citizens [国家卫生健康
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委 2021]. However, while the amount is steadily increasing, Chinese healthcare policies typically
cover less of a given individual’s total healthcare costs than seen in Japan, and this is even more
true when discussing more serious illnesses and chronic conditions, the latter of which are more
common in elderly populations than any other demographic cohort (Kong 2019; LaFave 2017).
Large discrepancies in access to and scope and quality of insurance between urban and rural
areas persist, although strides are slowly being made in this area (Cheng 2019; Shi 2018; Sun
2020; Zou 2020). Furthermore, the pension system in place for retirees has been buckling under
the weight of the country’s increasing older population (Jiang 2016). As a result, China’s
healthcare system cannot be described as fully developed in its current state.
The extant literature focuses heavily on the struggling pension system as a current
economic and logistical pain point for China when it comes to managing and providing for its
growing percentage of old people. There are many articles that focus on the increasing burden
placed on China’s old-age pension system, most of them pointing out that the system is so
strained because an increasing percentage of the population is relying on the pension as their
primary income source, while at the same time a decreasing amount of young people are paying
into the system, creating an unsustainable situation in which more money is being withdrawn
than is being put in or replenished (Jiang 2016, Shi 2018). This draws a causal link between the
struggling old-age pension system and the ongoing inversion of China’s population distribution.
It also implies that the pension system and the country’s healthcare infrastructure are unable to
keep up with the current pace at which China’s elderly population is expanding, and thus
healthcare costs are rising while needs go unmet.
An interesting trend found in the literature is the focus on long-term care, which is
closely tied to old age and multimorbidity, and its associated costs. The connection between
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long-term care and healthcare expenditures is so readily apparent in most studies’ results, in fact,
that many authors seem as if they cannot overstate its importance, arguing for an even larger
emphasis to be placed on long-term care costs when evaluating and predicting changes in
healthcare expenditures over time (Mori et al. 2019). One study examined the factors that are
related to higher dependence on and cost for long-term care at both the individual and municipal
level. Its findings show that, at the individual level, those who are less financially well-off, are
female, and have a higher care-need level are more likely to spend more on long-term healthcare
services, while at the municipal level, those located within larger metropolitan areas, possessing
a higher percentage of single elderly households, and with more nursing homes per capita
generally saw a higher level of average spending on long-term care (Jin et al. 2020).
Elsewhere, studies that simulated the impacts of attempts to prevent dependence on
long-term care through efforts to lower death rates even further and to prolong elderly people’s
years of good health before death, such as Japan’s ongoing Health Japan 21 project, actually
showed an associated increase in healthcare expenditures in the short term (Nishi et al. 2020).
The reasoning behind this is that increases in good health outcomes in the oldest age cohorts
would inadvertently alter the population structure to be even further skewed towards inversion,
with the increase in healthcare demand brought about by a larger proportion of elderly members
of society, even those in good health, outpacing the expected drop in costs from a decrease in
long-term care usage (Nishi et al. 2020).
This is a key driver in short-term healthcare expenditure increases, with efforts by both
China and Japan to improve the overall wellbeing of their respective elderly populations ending
up simultaneously contributing to each nation’s healthcare cost woes and the perpetuation of the
aging population phenomenon that is contributing to it (Nishi et al. 2020). However, it is
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important to note that these projects do show an overall decrease in associated healthcare
expenditures as the percentage of elderly persons dependent on long-term care decreases and
balances out the initial increase, pointing to a time-lag in this process.
Multimorbidity is a heavily focused-on topic in regards to drivers of healthcare costs, and
there is ample evidence to support the claim that its prevalence increases with age (Wang 2014).
This holds true for China and Japan as well. Both in terms of sheer number of times this
relationship is brought up in the extant literature on China and Japan in comparison to other
potential causal mechanisms, as well as how much each article on said topic stresses the impact
of multimorbidity on healthcare expenditures, it is not out of line to conclude that multimorbidity
is one of, if not the number one causal mechanism associated with population aging fueling
rising healthcare costs in the two nations in question.
Regarding China in particular, various authors assert that the nation’s healthcare system
has yet to properly account for the major burden that is multimorbidity and its associated
complications, despite the fact that up to “95% of healthcare expenditures on chronic conditions
are spent on multimorbidity” in large population centers such as Beijing (Chen et al. 2018).
Multimorbidity is widely accepted as being strongly associated with both “higher levels of health
service use and a greater financial burden,” with much of that increase in health service use
coming in the form of long-term care (Zhao et al. 2020). This brings us to the next significant
theoretical trend in the literature.
In addition to just looking at multimorbidity and/or long-term care usage in a vacuum,
what many of these studies also touch on is the connection between the two factors, with the vast
majority of the extant literature suggesting that the former contributes to an increase in the latter,
which then contributes to an increase in healthcare expenditures (Chen 2018; Mori 2019; Nagl
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2012). Furthermore, this trend is seen in studies on both China and Japan, despite one country
being generally farther along than the other in the aging population process (Chen 2018; Mori
2019). That strengthens the evidence that there is not only a causal relationship between
multimorbidity and healthcare costs and long-term care utilization and healthcare costs, but also
between multimorbidity and long-term care utilization as its own distinct causal link that makes
up a broader causal relationship.
This theoretical framework illuminates a one-two punch of long-term care and
multimorbidity contributing directly to rising healthcare expenditures in China and Japan. The
framework also shows that the two factors themselves are interlinked, with higher rates of
multimorbidity in the elderly leading to higher dependency upon long-term care services, which
ultimately leads to rising annual healthcare expenditures. While there are certainly other fairly
prominent theoretical trends in the literature, the dual focuses on multimorbidity and long-term
care, both separately and in conjunction with one another, are by far the most prevalent trends in
the body of literature on population aging and healthcare expenditures in China and Japan. This
makes sense, given that the majority of healthcare spending on the elderly in China and Japan is
a result of either multimorbidity, long-term care, or in most cases a combination of both.
In summation, these will constitute the main theoretical framework for this paper, as each
has a significant link to total healthcare expenditures and population aging. The findings of this
section and the literature review will be analyzed in conjunction with the main results of the
quantitative analysis portion, with the goal of forming a more comprehensive picture of the
impact of population aging on healthcare costs, particularly in regards to what is driving said
relationship.
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Chapter 4: Methods and Findings
Specifically, this study addresses the question of how the aging population phenomenon
affects total healthcare spending and eldercare needs as population aging progresses.
Additionally, in order to achieve a comprehensive and generalizable view of the interaction
between the population aging phenomenon and healthcare spending, the main quantitative
analysis of existing data is looked at in depth alongside the prevailing theoretical trends found in
the extant literature in Chapter 3, with the theoretical framework being reevaluated in light of the
quantitative findings. These are used as a framing device in order to suggest the likely causal
mechanisms that drive the impact of aging on healthcare expenditures, the discussion of which
will constitute Chapter 5. There is ample primary data to establish a clear broad picture of the
relationship between population aging and healthcare expenditures, but secondary sources are
necessary in order to gain a deeper understanding of the myriad of ways in which the two main
variables (population aging and healthcare expenditures) are connected.
The independent and dependent variables, respectively, are operationalized as follows:
population aging (percentage of a country’s population age 65 and above) and total healthcare
expenditures (combined public and private healthcare spending as a percentage of gross domestic
product). The methods and findings portion of this paper consists of two main sections - a
cross-sectional analysis for all countries and a time-series analysis of China and Japan. The
benefit of doing both a cross-sectional analysis and a time-series analysis is that the latter can
assess whether or not the theory holds over time rather than just as a snapshot. These chiefly
utilize correlations, linear regressions, and tests of statistical significance.
On that note, primary data was sourced from the Organization for Economic Cooperation
and Development, the United Nations, and World Bank databases, with the World Health
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Organization and the Population Reference Bureau databases providing supplementary statistics.
Health expenditures and percentage of population age 65 and above data were sourced from the
OECD’s health spending database and the World Bank staff estimates based on the age and sex
distributions of the United Nations Population Division's World Population Prospects: 2019
Revision, respectively, while GDP per capita data were gathered from the World Bank’s World
Development Indicators database.
To sum up, below begins Chapter 4, the description and presentation of the quantitative
data analysis, including key takeaways from each figure and explanations of their importance.
Following that is Chapter 5, a discussion section that combines the main tenets of the theoretical
framework discussed in Chapter 3 and applies them together with the results of the quantitative
analysis to synthesize a broader understanding of the population aging issue as it affects total
healthcare expenditures across the world and in China and Japan. This will include a discussion
of what the results mean going forward for the two countries, as well as what lessons and trends
can be extracted from their respective aging population crises and applied to other nations facing
the same looming societal threat.

Population Aging Around the World
While this paper focuses on China and Japan as a least similar pair, ultimately the goal in
doing so is to test the broader relationship between population aging and healthcare spending,
which is a trend found all across the globe. Therefore, it is important to have a grasp on that
relationship from a big picture point of view. To that end, a cross-sectional analysis was
performed by using data from the United Nations, the World Bank, and the OECD on 173
countries. The United Nations data on percent of population age 65 and above show that Monaco
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is the most aged society in the world, with approximately 35.15 percent of its population being
age 65 or above. At the other end, Niger is the least aged society in the world, with only 2.6
percent of its population being age 65 and above. This variable has a mean of 8.75, a median of
6.2, and a standard deviation of 6.36. The OECD data on total healthcare expenditures show that
the United States spends the most annually on healthcare, amounting to 16.9 percent of the
country’s GDP, while the Republic of the Congo spends the least annually on healthcare at just
2.14 percent. This variable has a mean of 6.45, a median of 6.23, and a standard deviation of
2.64. Lastly, the World Bank data show that Monaco has the highest GDP per capita at $190,513,
while Burundi has the lowest at $780. This variable has a mean of $21,051, a median of $13,164,
and a standard deviation of $21,712.
Starting with healthcare spending and aging, the two charts below illustrate the
relationship between healthcare expenditures as a percentage of GDP and percentage of
population aged 65 and above as a percentage of total population. Figure 2 shows the
relationship between the variables across all countries, while Figure 3 focuses on just developed
nations.
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Figure 2: Population Age 65+ VS. Total Healthcare Expenditures (2018) - World.
Source: World Bank staff estimates based on age/sex distributions of United Nations Population Division's World
Population Prospects: 2019 Revision and OECD (2021), Health spending (indicator). doi: 10.1787/8643de7e-en.

Figure 3: Population Age 65+ VS. Total Healthcare Expenditures (2018) - Developed Countries.
Source: World Bank staff estimates based on age/sex distributions of United Nations Population Division's World
Population Prospects: 2019 Revision and OECD (2021), Health spending (indicator). doi: 10.1787/8643de7e-en.
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As shown above, the relationship between total healthcare expenditures and population
aging exists across all nations, but the correlation is noticeably stronger when isolating it to just
developed countries. For the world, changes in population aging explain about a quarter (0.247)
of the cross-national variation in total healthcare expenditures. This jumps up to over forty
percent when examining just developed nations (0.414). Such a significant increase was
expected, and it makes sense given that developed countries have already completed their
demographic transitions in accordance with the Demographic Transition Model, meaning that as
a result people are living longer and having less children, which among other factors leads to
population aging. The models of fit on the two graphs differ slightly, but the general trend across
nations is still very clear.
Furthermore, even though the scatterplots above display a strong correlation between
population aging and total healthcare expenditures, I cannot yet rule out the possibility that the
relationship in question is spurious. In particular, a country’s income level (as measured by GDP
per capita) could be driving both populating aging and healthcare spending. As such, it is
important to control for this variable in order to ensure the relationship between aging and
healthcare is statistically significant.
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Figure 4: Population Age 65+ VS. Total Healthcare Expenditures (2018) - Developed Countries.
Source: World Bank staff estimates based on age/sex distributions of United Nations Population Division's World
Population Prospects: 2019 Revision and OECD (2021), Health spending (indicator). doi: 10.1787/8643de7e-en.

The bubble chart above shows the relationship between population aging and total
healthcare expenditures, with each bubble representing a different country and its size
corresponding to that country’s GDP per capita. The size of the bubbles do not seem to correlate
strongly with the Y axis whatsoever, with high and low GDP countries being equally scattered
across the graph, such as Qatar being close to the origin while another high GDP country like
Luxembourg is much farther to the right at point 14.2, 5.3. Even higher up is the United States at
15.8, 16.9. Low GDP countries fall all over as well, with Tanzania being at 2.6, 3.6 and Sierra
Leone being at 3.0, 16.1. Visually this graph gives little indication of any significant connection
between GDP per capita and total healthcare expenditures.
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But in order to rigorously test this and control for GDP per capita, a linear regression was
run using population aging (percentage of population age 65 and above) as the independent
variable, total healthcare expenditures (percentage of GDP) as the dependent variable, and GDP
per capita as the control variable to check for spuriousness as a result of countries with higher
GDP seeming to have higher levels of population aging. I wanted to test whether or not GDP per
capita was the actual influencer rather than population aging itself. Below is the linear regression
equation, and I used functions in Microsoft Excel to estimate the beta coefficients, the results of
which are displayed in Table 1 below.

Health expenditures = β0 + β1*%65&above + β2*GDPperCapita
Regression Analysis with Healthcare Expenditures as Dependent Variable (World)
Variables

Coefficient

Standard Error

t statistic

p value

Constant

4.650

0.300

15.502

2.358E-34

Percent 65 and
above

0.210

0.034

6.112

6.511E-09

GDP per capita

-1.896E-06

1.006E-05

-0.188

0.851

R2

0.250

Number of
countries

173

Table 1: Regression Analysis with Healthcare Expenditures as Dependent Variable (World).
Source: World Bank staff estimates based on age/sex distributions of United Nations Population Division's World
Population Prospects: 2019 Revision, OECD (2021), Health spending (indicator) doi: 10.1787/8643de7e-en., and
International Comparison Program, World Bank | World Development Indicators database, World Bank |
Eurostat-OECD PPP Programme 2018.

According to this model estimation, if a country has zero percent of its population at age
65 and above and zero GDP, then its health expenditures would be about 4.6 percent of its total
GDP. There are two key takeaways from this regression. First, for every percentage point
increase in population 65 and above, health expenditures as a percentage of GDP increase by
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approximately 0.21 percentage points. To put this into perspective, let us take Argentina, a
well-off country that is just now beginning to grapple with the emergent effects of population
aging, as an example. As of 2018, slightly over eleven percent of this South American nation’s
population consists of people aged 65 or above, qualifying it for aging population status. The
country’s annual total healthcare expenditures for that year accounted for 9.6% of its GDP. If
Argentina’s aging grew from its current level to that of, say, Switzerland, then the country would
see a jump to almost nineteen percent of its population being aged 65 and above and almost
twelve percent of its GDP being made up of healthcare expenditures alone.
Along the same lines, an even more extreme example would be that of Angola, a country
still in the process of developing, and the United States, a country that has comfortably occupied
developed status for decades. An increase in aging from the former to the latter would see
Angola facing an approximate fourteen percent increase in population aging as measured by
percent of people aged 65 and above, which would accompany a fifteen percent increase in total
health expenditures as a percentage of GDP.
Returning to Table 1, the second key takeaway from this linear regression is that it shows
that GDP per capita is not an influencing factor on the total health expenditures variable, as the p
value for GDP per capita, 0.851, is much higher than it would need to be in order to be
considered statistically significant in any way. In short, a p value is an indicator that assesses the
probability that the relationship between two variables happened to occur by random chance.
Generally, if this value is above 0.05, or a five percent chance, then the results are dismissed as
statistically insignificant. Such is the case for GDP per capita and total healthcare expenditures.
What we can ascertain from this finding is that the common assumption that more
developed countries spend proportionately more on healthcare in terms of GDP per capita when
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compared to less developed countries is not supported by the data. Rather, these more developed
countries have higher healthcare expenditures not because they are comparatively rich, but
because their populations are comparatively old. We know this because the linear regression
model produced a p value of 6.51E-09, which for all intents and purposes is essentially zero, for
the population age 65 and above variable. This indicates a very high level of statistical
significance, meaning we can conclude that not only is GDP per capita not a factor resulting in
any kind of spurious relationship between population aging and healthcare expenditures, but also
that population aging itself is a major driver of healthcare costs. These results are not only
statistically significant and substantive, but such an impact is noteworthy for its magnitude as
well, with population aging accounting for an average of nearly one fourth, or 25 percent, of all
change in total healthcare expenditures across all countries in the world, as indicated by the R2
value of 0.247, which denotes the magnitude of change.
With all of that said, however, the overall trend seen in the world at large cannot be
assumed to be the same for any given individual nation, with there always being a potential for
outliers. For that reason, I applied the same level of scrutiny to data for China and Japan as
individual cases of population aging as I did for the data on aging as a global issue. The
subsection below employs the same methods used above on the world data but in this case
focusing solely on the two main case studies of this paper, beginning with the multivariable
scatterplot below.
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Population Aging in China and Japan

Figure 5: Population Age 65+ and Total Health Expenditures (Japan 1960-2019, China 1970-2019).
Source: World Bank staff estimates based on age/sex distributions of United Nations Population Division's World
Population Prospects: 2019 Revision and OECD (2021), Health spending (indicator). doi: 10.1787/8643de7e-en.

The time-series analysis in Figure 5 uses data that cover a period of 59 years. The graph
above shows that from 1960 to 2019, the proportion of the total population aged 65 or over has
steadily increased in both China and Japan, with the latter seeing an especially steep increase. In
terms of when each country's aging became more pronounced, Japan’s percentage of its
population aged 65 and above began to increase more rapidly during the lost decade, whereas the
true effects of China’s one-child policy on the nation’s demographic transition did not show
themselves until later into the 1990s at the earliest. In line with those increases are each nation’s
total healthcare spending as a percentage of gross domestic product, which follows the same
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upward trend. Also noteworthy are the correlations for population aging and healthcare
expenditures in China and Japan displayed in Table 2 below.
Correlation Between Population 65+ and Health Expenditures
Country

Correlation

Japan

0.950

China

0.813

Table 2: Correlation Between Population 65+ and Health Expenditures.
Source: World Bank staff estimates based on age/sex distributions of United Nations Population Division's World
Population Prospects: 2019 Revision, OECD (2021), Health spending (indicator). doi: 10.1787/8643de7e-en., and
International Comparison Program, World Bank | World Development Indicators database, World Bank |
Eurostat-OECD PPP Programme 2018.

Elsewhere, we can look at the correlation between the percentage of the population aged
65 or older and total healthcare expenditures as a percentage of GDP. Table 2 establishes a strong
positive correlation between the two variables, which is found both in Japan and China’s
measurements. Figure 6 plots total healthcare expenditures as a function of population aging.

Figure 6: Population 65+ VS. Total Health Expenditures.
Source: World Bank staff estimates based on age/sex distributions of United Nations Population Division's World
Population Prospects: 2019 Revision and OECD (2021), Health spending (indicator). doi: 10.1787/8643de7e-en.
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Figure 6 gives coefficients of determination for each country’s aging and healthcare
relationships. These values indicate a high goodness of fit for China and Japan’s respective
regressions, meaning that the regression models have high accuracy in predicting where the data
will go. Japan in particular has a very high coefficient of determination at 0.9025. These
preliminary results show a definite relationship between population aging and healthcare
expenditures.
Just as I did previously with the data for all countries, I also performed a linear regression
analysis, using the same equation, on the data for just China and Japan. Figure 6 only looks at the
one to one, independent to dependent relationship between population aging and healthcare
expenditures for China and Japan. As such, isolating these two in this way is necessary in order
to control for the influence of GDP per capita and assess whether or not it has resulted in a
spurious relationship between the two aforementioned variables. Identical to the early linear
regression on all countries’ data, I needed to see whether the relationship was still there even
when accounting for GDP per capita. The results of this can be seen in Table 3 below.
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Health expenditures = β0 + β1*%65&above + β2*GDPperCapita
Regression Analysis with Healthcare Expenditures as Dependent Variable
(China and Japan)
Variables

Coefficient

Standard Error

t statistic

p value

Constant

2.531

1.0116

2.5021

0.0154

Percent 65 and
above

0.286

0.045

6.387

4.062E-08

GDP per capita

1.800E-05

1.375E-05

1.309

0.120

R2

0.432

Number of
observations

57

Table 3: Regression Analysis with Healthcare Expenditures as Dependent Variable (China and Japan).
Source: World Bank staff estimates based on age/sex distributions of United Nations Population Division's World
Population Prospects: 2019 Revision and OECD (2021), Health spending (indicator). doi: 10.1787/8643de7e-en.

According to this model estimation, health expenditures would be around 2.53 percent of
total GDP if the population did not consist of any persons aged 65 and above and if GDP was
zero. This regression has two takeaways that mirror the results of the previous one. First, for
every percentage point increase in population 65 and above, health expenditures as a percentage
of GDP increase by approximately 0.29 percentage points, which is even higher than that of the
all-countries regression. Furthermore, the second key takeaway from this linear regression is that
it maintains the result that GDP per capita is not an influencing factor on total health
expenditures, as the p value for GDP per capita in this case is 0.196, which is still much higher
than it would need to be in order to be declared statistically significant. This means that there is
no spuriousness with GDP per capita, as the relationship between population aged 65 and above
and total healthcare expenditure remains significant, with a p value of 4.06E-8 (which is
essentially zero), when controlling for GDP per capita.
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This indicates a very high level of statistical significance, meaning we can conclude that
not only is GDP per capita not a factor resulting in any kind of spurious relationship between
population aging and healthcare expenditures, but also that population aging still presents as a
major driver of healthcare costs, even more so here when looking at the data for China and Japan
in comparison to the data for all countries. In this regression, the R2 value is 0.432, meaning that
across China and Japan, population aging accounts for a staggering 43 percent of the change seen
in total healthcare expenditures. This is a large jump up from the already sizable 25 percent seen
across all countries, which lends further evidence to the notion that population aging is a large
influencer of total healthcare expenditures, especially in more developed, and therefore on
average older, nations.
The quantitative analysis presented in this chapter grants valuable insights into the
relationship between population aging and healthcare expenditures, both on the world stage,
when looking only at developed nations, and also within China and Japan respectively. First and
foremost, the results confirm that the population aging phenomenon and increases in total
healthcare expenditures are related in a statistically significant manner, even when taking into
account income level, on both the global level and for China and Japan specifically. Not only
that, but the strength of that relationship is very strong. Scatter plots indicated a high goodness of
fit, which was supported by the correlation results showing a close association (0.950 for Japan
and 0.813 for China). The linear regressions strengthened the results even further by controlling
for GDP per capita and showing p-values extremely close to zero, indicating a very high level of
statistical significance and allowing for the conclusion that income level is not resulting in the
existence of any spurious relationship. Furthermore, each regression revealed that not only does
population aging have an impact on total healthcare expenditures, but that said impact is quite
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substantial, with R2 values showing that population aging accounts for 25 percent, or a whole
fourth, of the entire change in total healthcare expenditures seen across the globe, with that
figure rising to an even higher 29 percent when looking at just China and Japan.
Such a tight relationship between the two main variables, as well as with that degree of
magnitude, show definitively that population aging is a substantial driver of healthcare spending.
The question now is what exact aspects of population aging are fueling this trend, what that
means for countries like China and Japan going forward as the severity of their respective aging
population crises continues to worsen, and what lessons can be learned from their situations with
the goal of mitigating the same level of impact in other countries that have either yet to face
population aging or are just now grappling with it in earlier stages. The goal of the following
chapter is to speculate upon and provide answers to these questions.

Chapter 5: Discussion
This chapter dives into the implications of the quantitative findings of Chapter 4 within
the context of the prevailing ideas presented in the literature review (Chapter 2) and especially
the theoretical framework (Chapter 3). It seeks to marry the strongest trends found in the extant
literature with results from the quantitative analysis in order to delineate the causal mechanisms
within the umbrella of population aging that are driving its impact on healthcare expenditures.
Doing so will paint a comprehensive picture of the broader, complex societal issue at hand,
thereby lending a high level of generalizability to this study's findings and as a result making it
more beneficial when attempting to understand the relationship between aging and healthcare
spending not just in China and Japan, but across the world as well.
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Immediate Implications
This study adds to the existing literature by supporting the conclusion that population
aging is a major contributor to trends of increasing healthcare expenditures, and the
reinforcement of this finding allows for a higher level of confidence when discussing the issue of
population aging and healthcare. Additionally, my work shows that these results hold true both
worldwide and for China and Japan individually. Despite all their differences, the same trend
among the main variables exists over a long term examination of trends in two countries that
have almost diametrically different histories when it comes to aging, healthcare reform, and
social and economic development. That fact naturally necessitates a discussion on what
short-term and long-term implications population aging and its associated increase in annual total
healthcare expenditures will have for both countries, as each face struggles unique to their own
respective situations while also encountering some overlapping challenges.
From the information gathered in the literature review, it is likely that by virtue of being a
developed nation with the level of healthcare infrastructure development to match, Japan, so long
as the country makes adjustments in some key areas, will fare somewhat decently at least when it
comes to accommodating the ever-growing, complex healthcare needs of a society that continues
to grow older and older. With that said, while the country may be able to provide care for the
ever-increasing proportion of elderly people in its society, its overall population decline shows
no signs of stopping. Japan’s population is expected to decrease from its current approximately
126 million people to around or below 100 million by the year 2050 (Statistical 2017). And as far
out as 2100, United Nations estimates show Japan’s population dipping down even further to 85
million unless it begins taking drastic steps now to address its aging population crisis (United
Nations 2019). This precipitous drop down to two-thirds of its current population in the span of
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less than a century will wreak havoc on the nation’s economy, and its impact will be felt across
all areas of society (厚生労働省 2014). Some major examples of this are most likely to include
but are not limited to the following: stunted economic growth or even decline, unhealthy
fluctuations in inflation rates, a straining of the government’s ability to provide adequate social
and medical resources for elderly people, changes in the responsibilities and functioning of the
family (often manifesting in the form of increased stress placed on younger members to care for
elder members, as the latter grow in number while the former decline), and shifting practices of
work and retirement (Vlandas 2018).
If Japan wants to both manage its growing elderly population and mitigate the damage
said aging population will cause on all aspects of its society, then the generally agreed upon
changes the country needs to make are in regards to its outdated policies on immigration that are
highly restrictive to foreigners (Milly 2020). Otherwise, those will continue to contribute to
Japan’s increasing annual healthcare expenditures and will place further unneeded economic
strain on its rapidly dwindling working age population.
On the other hand, despite making strides in recent years to improve the baseline quality
and accessibility of its healthcare, it is difficult to see China navigating these waters without
some rough waves in the short term. Much of this is due to the fact that the country’s aging has
occurred prematurely, and thus it has not yet had the chance to put into place the infrastructure
needed to attain neither healthcare quality nor health outcomes even close to being on par with
that of Japan or even most developed nations (Kong 2019). China needs more time to prepare but
simply does not have it. The other main problem China will face in the short term is a simple but
daunting one - its sheer population size. Even at the country’s current level of population aging
of around 11 percent of its 1.4 billion people, China already possesses more total elderly persons
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than the entire population of Japan, whose population currently sits at approximately 126 million
people (United Nations 2019). This vast discrepancy alone is enough to cause China significant
issues and increase its healthcare spending, especially when coupled with the consideration that
its current healthcare system is marred by unequal access and quality based on geographical
location (Cheng 2019; Shi 2018; Sun 2020; Zou 2020). And this all is on top of an old-age
pension system that is in need of urgent reform, lest it collapse (Jiang 2016). Unless it can cut
back on costs while simultaneously greatly bolstering its healthcare infrastructure, a task
essentially impossible due to its very nature, China will continue to see its healthcare spending as
a percentage of its GDP rise for the foreseeable future.
With all that money being spent on healthcare and medical systems for the elderly every
year, there exists a very real potential for healthcare expenditures to crowd out spending in other
sectors of the economy, likely to those sectors’ detriment (Ishikawa 2019; Williams 2019). As
the needs of a country’s greying population continue to grow, that impact will be felt most
acutely on the healthcare sector itself, necessitating further spending increases, which will take
away money that could be spent, and in some cases may need to be spent, on sectors such as
infrastructure. The effects of this will be compounded by the dwindling working age population,
the process of which both contributes to and is in some ways a product of slowing or even
negative GDP growth rates (Feng et al. 2014; Nie 2016). Relating to that, while China’s GDP
growth is projected to slow by mid century, it is expected that Japan will see negative GDP
growth rates year over year by as early as 2030 (Yasutake 2012). The takeaway from all of this is
that money will be spread more thinly than ever in recent memory as the related forces
mentioned above combine to exert massive strain on the declining working age populations, and
thus the financial backbones, of each country’s economy, particularly in the case of Japan.
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However, China may have more to worry about in the long run if the nation does not
utilize its current time wisely. Otherwise, the country will be dealing with all the near future
consequences described above that are at this point almost certain and unavoidable for Japan,
except simultaneously on a vastly larger population scale and with much less developed
healthcare infrastructure. If China does not learn from Japan’s example, then, at the risk of
sounding alarmist, the resulting crisis could prove catastrophic for the large East Asian nation.
On top of the expected major increases in healthcare expenditures yearly, this could see the
complete crumbling of the already buckling pension system, which would leave hundreds of
millions of elderly Chinese without a financial safety net. Failure to rectify this, coupled with
gaps in coverage, would lead to untimely deaths, especially in China’s less developed, rural areas
(Cheng 2019; Nie 2020). Urban areas would also struggle, as the population crisis continues to
exacerbate the 4-2-1 phenomenon and place further economic burden upon China’s younger
cohorts (Jiang 2011). Luckily, the country does have time on its side, at least more so than Japan,
but it still needs to act now.
Furthermore, it needs to do more than just its current three child policy, which, should it
be successful, would help alleviate some of the strain placed on China’s working age population,
and as an extension its splintering pension system propped up by said cohorts, by supplementing
it with more young people (Roser 2013). Even so, the three child policy alone would almost
surely not be enough to act as a full course correction for China’s artificially accelerated
demographic transition, as population aging is just not a simple enough issue to be solved with a
magic bullet type of policy (Feng et al. 2014). On top of that, if history should serve as any
guide, said policy is unlikely to do much at all in the face of such a pervasive crisis (Jowett
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1991). More fundamental change needs to occur at the societal level in both China and Japan if
they truly wish to tackle population aging head on.
In the case of the latter, this would mean Japan loosening its notoriously strict
immigration policies and submitting to the ideas of a future Japan that is not ethnically
homogenous, a feat that may only occur in dire circumstances, at which time much of the
preventable damage would have already been done (Milly 2020). Still, it is vital that they strive
to do so regardless. The Japanese government is presently enacting some minor measures to
combat population aging, such as campaigns encouraging young Japanese people to simply have
more sex, given that the country has some of the lowest intimacy rates in the world, and even
policies that pay women in certain prefectures per baby beared and provide them with free
daycare services and subsidized preschool (“Tackling” 2020). However, experts agree that these
efforts will not be nearly enough to address Japan’s continually worsening aging crisis, instead
pointing to a complete reform of the nation’s immigration policies as its best bet (Milly 2020).

Long-term Impacts
Regardless of what happens with China and Japan’s respective population aging crises,
given my new empirical data, we are more informed on the various potential outcomes than
before. The results also grant enhanced validity and an understanding of the relationship between
population aging and healthcare expenditures, and it reaches a similar conclusion on that
relationship as seen in the Milena article on Italy that also found that healthcare expenditures are
more closely correlated with population aging itself, rather than other similar metrics such as life
expectancy or GDP per capita (Milena 2017). Similarly, this refutes the claims made by de
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Meijer and Williams that healthcare expenditures are primarily tied to price changes and
technological developments in the healthcare fields (de Meijer et al. 2013; Williams et al. 2019).
Though this study places special emphasis on population greying in China and Japan, the
implications of my findings are more broadly applicable to the rest of the world’s nations that are
facing the same issue. This is true because, population aging is a natural demographic
phenomenon that will eventually impact every country on Earth assuming they continue to
develop and progress through their demographic transition stages in a similar manner to
post-industrial nations such as the United States, much of Europe, and of course Japan (Roser
2013).
China offers a blueprint for larger scale population aging, which will be important for
some of the world’s most populous countries that are still seeing substantial population growth,
such as India, Indonesia, Pakistan, Nigeria, etc., once they reach a higher level of development.
With that said, the circumstances of both China and Japan act as cautionary tales for the rest of
the world. And given that it is the single most extreme example of population aging in the world,
Japan in particular offers a glimpse into uncharted waters. It would be of great benefit to the
world to learn from their examples, both in terms of how they arrived at their current situation,
what they have done wrong, and what they have done right. It is equally important to examine
both of these elements in order to stave off and then mitigate the most drastic potential
consequences of population aging. I say stave off and then mitigate because, in light of all the
research done on population aging up until this point, there exists no evidence to suggest that
population aging can be completely avoided (Roser 2013). The world must realize this and begin
to develop strategies and enact plans now in order to be adequately prepared for the inevitable.
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The hope is that this way countries can better manage the population aging phenomenon and
lessen the severity of its impact on all facets of society.
As we know from connecting the extant literature with my quantitative analysis, this
means heavily bolstering healthcare infrastructure, not just in scope of access to coverage, but
also in specialized areas of medical care as well (Ishikawa 2019). In addressing the most pressing
among them, healthcare systems need to focus their efforts on developing and acquiring the
resources for more robust long-term care treatment and facilities, as well as looking at ways to
most efficiently and effectively manage cases of multimorbidity and chronic illness that are so
common in elderly populations (Lehnert 2011). As seen in the Marengoni study in Germany and
others, an increase in the proportion of elderly persons that make up a population is very closely
associated with multimorbidity, and the authors conclude that it leads to increased personal
healthcare costs as well as health service consumption (Marengoni et al. 2011). This supports my
empirical findings because it further shows that countries are not spending more on healthcare
due to their higher GDP per capita measures. Rather, they are spending more on healthcare
because their populations are getting older and require more advanced and comprehensive
treatment. This also gives us a causal link between healthcare expenditures and multimorbidity.
On that note, chronic illness is another trend that emerged from the extant literature, and
it too supports the conclusion that population aging is driving an increase in healthcare
expenditures both around the world and in China and Japan specifically, in part because the
literature heavily suggests that an increased prevalence of chronic illness itself is a main
component of population greying. This was noted most clearly in the Graves and Zheng studies
that looked at the relationship between chronic illness and direct healthcare costs in Australia,
another aging society. Graves notes, “As the elderly population grows, costs are likely to rise
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unless cost-effective intervention strategies are implemented as a matter of routine” (Graves
2014). This ties together with the need for long-term care resources, since chronic illnesses are
by definition not something that can be as easily treated and permanently dealt with like a simple
cut or a scrape. Instead, they are much more complex issues that persist for long periods of time,
necessitating massive investment in both cost reduction strategies in addition to long-term care
facilities that are better equipped to treat and manage chronic conditions (Chen 2018; Marengoni
et al. 2011).
Next I want to address the red herring effect that popped up in the extant literature. This
is a hypothesis that describes a perceived overstated emphasis on population aging as a driver for
increased medical costs. However, the validity of said argument is contested among scholars.
Though authors such as Hyun point to aging not being as important as some make it out to be
when discussing rising healthcare expenditures, my study provides a different perspective (Hyun
et al. 2016). The literature in conjunction with my findings makes it abundantly clear that
population aging is a significant driver of total healthcare expenditures. And more specifically, it
reveals the various facets of the population aging phenomenon itself that contribute most to that
impact of healthcare costs, being the aforementioned increase in chronic illnesses,
multimorbidity, and the need for better long-term care. These health complications are, much
more often than not, inherently elderly issues that just develop naturally with age. Thus, when
viewed on a larger societal scale, it is clear to see that these issues that primarily exist in the
oldest cohorts of any given population are causing healthcare expenditures to rise in tandem with
an increase in prevalence of said health complications. This points to the red herring effect being
a false hypothesis, and in general the findings of this study support the idea that such a fixation
on the questionable at best validity of the red herring effect obscures the need for meaningful
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policy change to combat the intertwined and very real threats of population aging and rising
healthcare costs, with Breyer claiming that the bulk of studies on the red herring effect are
inconclusive at best anyway (Breyer 2020). Dealing with the causal mechanisms should be the
main focus.
In terms of the human impact of those causal mechanisms, there are researchers out there
looking to prevent or at the very least delay the onset of chronic illnesses and instances of
multimorbidity, as those types of diseases, such as Alzheimer’s and Parkinson’s, often have
severe complications and contribute to a significant erosion of a person’s autonomy and quality
of life (Takechi 2019). However, treatments for many of these chronic illnesses are still on the
cutting edge of medical science and have not reached the point to where they can be
implemented practically, which is why the pursuit of delayment methods is so vital to countries
grappling with population greying (Takechi 2019). The extension of an elderly person’s healthy
years before they pass away is not only important for improving their quality of life, but it also
has the added benefit of delaying the onset of expensive healthcare cost increases as well. The
healthier countries’ healthcare systems can make elderly people and the longer they can keep
them that way, the less money countries will have to spend in the long run. All of this is to say
that upstream prevention and delayment methods are just as important as downstream mitigation
and management efforts.
Additionally, an important fact that countries need to realize is that a comparatively small
increase in healthcare spending in the present can eliminate the need for a dramatic increase in
the future because newly aging nations will be better prepared from the start. Otherwise there
will be instances in which countries end up looking like present day Japan, which by
comparison, had no pre-existing guide to look towards for help. With that said, they should also
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be wary of making too radical of changes in short periods of time, lest they do as China did,
overcorrecting for population growth and ending up thrusting themselves prematurely into being
an aging society.

Chapter 6: Conclusion
This study set out to examine the population aging phenomenon and its impact on
healthcare costs, as well as what aspects of population greying appear to be contributing to the
trend of rising annual total healthcare expenditures. The most important finding is that
population aging does indeed have a major impact on healthcare costs. However, the simplicity
of the above statement belies the all-encompassing nature of this societal issue. It is impossible
to overstate the gravity of the situation for both already advanced aging countries like Japan as
well as countries in the beginning stages of population aging like China. In the latter’s case, this
is especially true given its unique situation as being comparatively underdeveloped for its current
level of aging due to poor political planning (Kong 2019).
Furthermore, while this study puts China and Japan in the spotlight and uses them as least
similar pairs, the primary purpose of undertaking this research task was to look at their results,
extract major trends and observations, and apply those to test a broader theory on the relationship
between the population aging phenomenon and healthcare expenditures. It was vital for these
results to be generalizable to other places in the world because it not only allows for us to be
more informed about the issue on a macro level, but it also functions as a blueprint from which
other countries can learn. After all, population aging will impact all nations at some point in their
futures, regardless of how far along they currently are in terms of demographic transition and
level of overall development (Roser 2013).
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In terms of the most important findings and takeaways from this study, there are multiple.
First and foremost, the qualitative analysis showed definitively that population aging is a major
contributor to increasing healthcare expenditures in both statistical significance and order of
magnitude. Even when controlling for GDP per capita in the linear regression analyses, this
relationship held true and showed that GDP per capita does in fact not possess a statistically
significant influence on annual total healthcare expenditures. This was the case when looking at
both all countries in the world as well as China and Japan specifically.
What is more, the quantitative findings lend credence to the major trends found in the
theoretical framework derived from the extant literature regarding potential causal mechanisms
driving population aging. In light of the empirical evidence of this study in conjunction with the
work done by other researchers on the subject, we can reasonably conclude that the following
specific, interrelated aspects of population aging are contributing most to its effect on healthcare
expenditures: increased prevalence of multimorbidity, chronic illnesses, and the need for
long-term care infrastructure and programs. These three side effects of population aging are
responsible for the majority of aging’s impact on medical costs (Graves 2014; Jin et al. 2020;
Lehnert 2011; Marengoni et al. 2011). This also disproves the red herring effect theory seen in
the extant literature, with my findings instead providing much evidence to support not just the
association between the study’s two main variables, but more importantly the causal relationship
that links them.
With that said, one limitation of this study is that, no matter how heavily suggested it may
be, it is very difficult to declare the existence of a complete causal relationship due to the
complex nature of the issue being studied. Population aging and healthcare expenditures are both
intertwined with so many other factors that it is impossible to completely rule out the possibility
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that there is some other variable out there that is resulting in spuriousness. That is simply the
nature of research like this and is a limitation that should always be mentioned, despite how
miniscule and improbable of a chance it may be. However, I do want to stress that the results of
my study make it very, very unlikely that such a spurious correlation exists, and I want to
re-emphasize the high level of validity present in my findings. I am given no reason to believe
that there are any outlying spurious variables accounting for the strong correlation between
population aging and total annual healthcare expenditures.
One last thing that warrants discussion is the impact of the COVID-19 pandemic on
healthcare expenditures. While this study used data collected prior to the onset of the pandemic,
COVID-19 could have a short-term impact on current and near-future healthcare spending
globally. There are multiple reasons to suspect this. First and most obviously, more people have
required urgent medical care over the past year and a half, with hospitals worldwide facing issues
of overcrowding, particularly before the creation and distribution of the vaccine. This points to a
potential spike in healthcare expenditures. However, another side of this situation is that the virus
is most deadly when it affects elderly people, who often pass away relatively quickly following
infection, which could mean that healthcare spending might not increase as much as expected.
The last unknown factor is the prevalence of long COVID and how the increased medical
needs of those afflicted with it may impact spending on long-term care. This will likely look
different depending on how well a country has weathered the pandemic, with places like Japan
and China having fared relatively well, while countries such as France and Italy have
experienced a large number of deaths related to COVID-19, mostly in the elder cohorts
(Coronavirus 2021). Except for China, all the countries just mentioned have world-class
healthcare systems, but their levels of population aging likely made it difficult to mitigate deaths
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during the pandemic, particularly in Italy, which experienced one of the earliest and most severe
outbreaks (Coronavirus 2021). It is then reasonable to assume that Japan, a nation similarly
advanced in its level of population aging, would have experienced comparable misfortune. In
fact, the Japanese government was very worried at the onset of the pandemic about the potential
strain their aging population would place on the country’s healthcare system, and yet Japan has
navigated the pandemic quite well overall, even pulling off the Olympics without much issue
(Coronavirus 2021). Aside from the strict measures the Japanese government took to control the
spread of the virus early on, this could also be related to the simple but overlooked fact that,
unlike people here in America for example, Japanese people have for decades been wearing
masks in public whenever they get sick. As a result, it has become a normalized part of their
society, which is also known for prioritizing the wellbeing of the community over that of the
individual. This is in contrast to the hyper-individualism seen in the United States and certain
other countries that can often result in the prioritization of peoples’ personal rights at the expense
of the broader population’s well being, which is to say that there is likely a cultural aspect at play
here as well. Regardless, all of this is purely speculative, but it is worth keeping in mind for
future research in the areas of population aging and healthcare spending.
In summation, population aging is one of the most serious issues facing more developed
nations today, and it will become a similar threat to currently less developed nations in the future.
Chief among these potential impacts is a drastic increase in healthcare expenditures. There exists
a debate within the extant literature on the subject of to what extent aging impacts medical
spendings and in what ways that relationship manifests. This study adds to the existing body of
work on population aging by showing that there is a clear, strong, and statistically significant
relationship between the two variables. And when viewed together with the main theoretical
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trends found in the literature, the results support established, prevailing notions as to what
exactly about population aging makes it such a large contributor to increased healthcare costs.
Zooming out a bit, the high level of generalizability of the least similar pair of China and
Japan make their situations quite useful from a learning perspective for other nations around the
world that are either already grappling with population aging or still have it looming in the
distance. In either case, steps based on what is happening in China and Japan can be taken now
in other nations to alleviate the worst impacts of population aging and the logistical and
economic strains it places on a given country’s healthcare system. The results of this study
illuminate intricacies of the relationship between population aging and total healthcare
expenditures, test and support conclusions seen in the extant literature regarding the causal
nature of said relationship, serve as a guide for other aging countries, and allow us to be more
informed about the issue going forward, all of which are beneficial in combating this major
societal issue. Population aging is inevitable, but with the right actions taken and preparations
put in place, its worst consequences are certainly able to be avoided and the rest of its impact
managed.
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